MS&L brings in Brown amid senior-level resignations

Manning Selvage & Lee (MS&L) was this week the fulcrum of the most dramatic simultaneous people-moves in the healthcare public relations sector for many months.

Bradford: quit after a decade
Bradford: quit after a decade

The agency's long-serving UK health director Sally Bradford – its most senior London-based health staffer – is leaving after a decade, apparently to relocate to Bath, while Annabel Fiddian-Green is off to Red Door Communications.

But MS&L has moved swiftly to bring in Carolyn Brown, the former UK healthcare boss of Countrywide Porter Novelli (now Porter Novelli UK), as head of international healthcare.

Bradford's contract runs until August but her final day is undecided. UK chief executive Nicholas Walters said: ‘She has done a wonderful job and we wish her all the best.'

Fiddian-Green, who heads what MS&L refers to as its ‘advocacy centre of excellence', will leave at the end of June, starting at Red Door on 17 July in a board-level role.

MS&L has yet to start recruiting for a replacement for Bradford, ‘but will in the future have someone in the role', Walters told PRWeek.

He said plans were still being thrashed out as to how Fiddian-Green, who joined as an associate director in 2002, would be replaced.

Brown will start at MS&L next week. She has most recently worked at UCB Pharma in a global comms role split between the UK and Belgium. She left PN in 2003.

MS&L boasts healthcare accounts including Sanofi-Aventis's pre-launch obesity drug Acomplia, Lilly's impotence brand Cialis and Pfizer's anti-arthritis drug Celebrex.

Bradford and Fiddian-Green's resignations from MS&L follow other senior exits at the Publicis Group-owned agency's London health division: associate  director Vicky Kelham left late last year (also to join Red Door), while fellow
associate director Rachel Allen quit to go freelance.

Jennifer Garratt remains in charge of the agency's UK business.

Fiddian-Green is the first board-level appointment from outside its own ranks that Red Door has made since launching six years ago.

She will direct, manage and build pan-European and global business, which currently includes work for GlaxoSmithKline (pain), Novo Nordisk (diabetes) and Sanofi Pasteur MSD (vaccines).

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in